These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3583487)

  • 1. Study on pulmonary, prostatic and renal (medulla and cortex) distribution of sagamicin at different time intervals.
    Fraschini F; Braga PC; Scaglione F; Zanollo A; Politi P; Odero R; Trazzi R
    Int J Clin Pharmacol Res; 1987; 7(1):51-8. PubMed ID: 3583487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics in serum and sputum of sagamicin administered intramuscularly to patients.
    Fraschini F; Scaglione F; Scarpazza G; Marchi M; Braga PC
    Chemotherapy; 1987; 33(2):85-92. PubMed ID: 3568801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal parenchymal accumulation of aminoglycoside antibiotics in rats.
    Luft FC; Kleit SA
    J Infect Dis; 1974 Dec; 130(6):656-9. PubMed ID: 4427081
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration of gentamicin in serum, urine and urogenital tissue in man.
    Alfthan O; Renkonen OV; Sivonen A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:92-4. PubMed ID: 4521610
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats.
    Fabre J; Rudhardt M; Blanchard P; Regamey C
    Kidney Int; 1976 Dec; 10(6):444-9. PubMed ID: 1011538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].
    Fabre J; Balant L; Rudhardt M; Blanchard P
    Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2677-82. PubMed ID: 114976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of antimicrobial agents in male genital organs].
    Kataoka N
    Hinyokika Kiyo; 1983 Oct; 29(10):1219-30. PubMed ID: 6681499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM; Comte F; Spach MO
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic pharmacokinetics in newborns.
    Smith AL
    Mead Johnson Symp Perinat Dev Med; 1982; (21):52-6. PubMed ID: 6765460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated distribution of norfloxacin in the medullary-cortical part of the kidney in man.
    Scaglione F; Ferrara F; Braga PC; Zanollo A; Esposti D; Fraschini F
    Int J Clin Pharmacol Res; 1986; 6(5):351-4. PubMed ID: 3781697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tobramycin: pharmacology in man].
    Brogard JM; Harf C; Pinget M; Lavillaureix J
    Nouv Presse Med; 1974 Apr; 3(0):59-64. PubMed ID: 4600180
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminoglycoside monitoring: timing of peak levels is critical.
    Blaser J; Simmen HP; Gonzenbach HR; Sonnabend W; Lüthy R
    Ther Drug Monit; 1985; 7(3):303-7. PubMed ID: 4049468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.
    Giuliano RA; Verpooten GA; De Broe ME
    Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of tobramycin.
    Horikoshi N; Valdivieso M; Bodey GP
    Am J Med Sci; 1973 Dec; 266(6):453-8. PubMed ID: 4774079
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study on renal accumulation of aminoglycoside antibiotics.
    Fujita K; Fujita HM
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):47-51. PubMed ID: 3988393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intrarenal distribution of aztreonam in healthy and diseased kidneys: clinical therapeutic implications.
    Watson AJ; Stout RL; Whelton A
    J Infect Dis; 1984 Nov; 150(5):631-5. PubMed ID: 6541673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Accumulation and persistence of aminoglycosides in the renal parenchyma].
    Rudhardt M; Blanchard P; Fabre J
    Nouv Presse Med; 1978 Nov; 7(42):3819-23. PubMed ID: 714684
    [No Abstract]   [Full Text] [Related]  

  • 19. Norfloxacin penetration into human renal and prostatic tissues.
    Bergeron MG; Thabet M; Roy R; Lessard C; Foucault P
    Antimicrob Agents Chemother; 1985 Aug; 28(2):349-50. PubMed ID: 3834837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dose regimen on renal accumulation of aminoglycosides.
    Giuliano RA; Pollet DE; Verpooten GA; Scharpé S; Paulus GJ; De Broe ME
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):277-9. PubMed ID: 7165429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.